famotidine and Cancer of Liver

famotidine has been researched along with Cancer of Liver in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (37.50)	18.2507
2000's	4 (50.00)	29.6817
2010's	1 (12.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Knupp, C; Quan, F; Quan, W; Walker, P	1
Jackson, S; Khan, N; Quan, W; Ramirez, M; Taylor, WC; Vinogradov, M	1
Quan, F; Quan, W; Ramirez, M; Taylor, C; Vinogradov, M; Walker, P	1
King, LA; Quan, FM; Quan, WD; Walker, PR	1
Kanakia, RR; Nanivadekar, SA; Rajagopalan, K; Sawant, PD; Shroff, CP; Vishwanath, N	1
Hazama, S; Nishida, M; Oka, M; Shimizu, R; Shimoda, K; Suzuki, M; Suzuki, T; Yano, K; Yoshino, S	1
Kawabe, T; Kobayashi, K; Matsumoto, S; Morishima, T; Okamoto, T	1
Hazama, S; Iizuka, N; Murakami, T; Oka, M; Shimizu, R; Suzuki, T; Yano, K; Yoshino, S	1

Trials

2 trial(s) available for famotidine and Cancer of Liver

Article	Year
Administration of high-dose continuous infusion interleukin-2 to patients age 70 or over. Cancer biotherapy & radiopharmaceuticals, 2005, Volume: 20, Issue:1 Topics: Adenosine; Aged; Aged, 80 and over; Aging; Capillary Leak Syndrome; Famotidine; Hemodynamics; Humans; Immunotherapy; Infusions, Intravenous; Interleukin-2; Kidney Neoplasms; Killer Cells, Lymphokine-Activated; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Time Factors; Treatment Outcome	2005
Intraarterial combined immunochemotherapy for unresectable hepatocellular carcinoma: preliminary results. Cancer immunology, immunotherapy : CII, 1994, Volume: 38, Issue:3 Topics: Aged; Carcinoma, Hepatocellular; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Famotidine; Female; Humans; Immunity, Cellular; Immunotherapy; Interleukin-2; Killer Cells, Natural; Liver Neoplasms; Lymphocyte Subsets; Male; Middle Aged; Picibanil; Survival Analysis; Tumor Necrosis Factor-alpha	1994

Article

Year

Administration of high-dose continuous infusion interleukin-2 to patients age 70 or over.

Cancer biotherapy & radiopharmaceuticals, 2005, Volume: 20, Issue:1

Topics: Adenosine; Aged; Aged, 80 and over; Aging; Capillary Leak Syndrome; Famotidine; Hemodynamics; Humans; Immunotherapy; Infusions, Intravenous; Interleukin-2; Kidney Neoplasms; Killer Cells, Lymphokine-Activated; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Time Factors; Treatment Outcome

2005

Intraarterial combined immunochemotherapy for unresectable hepatocellular carcinoma: preliminary results.

Cancer immunology, immunotherapy : CII, 1994, Volume: 38, Issue:3

Topics: Aged; Carcinoma, Hepatocellular; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Famotidine; Female; Humans; Immunity, Cellular; Immunotherapy; Interleukin-2; Killer Cells, Natural; Liver Neoplasms; Lymphocyte Subsets; Male; Middle Aged; Picibanil; Survival Analysis; Tumor Necrosis Factor-alpha

1994

Other Studies

6 other study(ies) available for famotidine and Cancer of Liver

Article	Year
Pulse infusion interleukin-2 with famotidine and cyclophosphamide has activity in previously treated metastatic melanoma. Cancer biotherapy & radiopharmaceuticals, 2010, Volume: 25, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Drug Administration Routes; Famotidine; Female; Humans; Infusions, Intravenous; Interleukin-2; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Palliative Care	2010
High-dose continuous infusion plus pulse interleukin-2 and famotidine in melanoma. Cancer biotherapy & radiopharmaceuticals, 2004, Volume: 19, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Drug Therapy, Combination; Famotidine; Female; Humans; Infusions, Intravenous; Interleukin-2; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Melanoma; Middle Aged; Pulse; Skin Neoplasms; T-Lymphocytes, Cytotoxic	2004
Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer. Cancer biotherapy & radiopharmaceuticals, 2008, Volume: 23, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Renal Cell; Cyclophosphamide; Famotidine; Female; Humans; Infusions, Intravenous; Interleukin-2; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Invasiveness; Treatment Outcome	2008
Primary gastrinoma of the liver. Indian pediatrics, 1994, Volume: 31, Issue:9 Topics: Child; Famotidine; Gastrinoma; Humans; Jejunostomy; Liver Neoplasms; Male; Zollinger-Ellison Syndrome	1994
Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer research, 2000, Jul-15, Volume: 60, Issue:14 Topics: Animals; Cell Adhesion; Cell Nucleus; Cimetidine; Colorectal Neoplasms; Dose-Response Relationship, Drug; Down-Regulation; E-Selectin; Endothelium, Vascular; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Famotidine; Histamine H2 Antagonists; Humans; Interleukin-1; Liver Neoplasms; Mice; Mice, Nude; Microscopy, Confocal; Neoplasm Transplantation; NF-kappa B; Oligosaccharides; Ranitidine; RNA, Messenger; Sialyl Lewis X Antigen; Transcriptional Activation; Tumor Cells, Cultured; Umbilical Veins	2000
[Intraarterial combination immunotherapy in hepatocellular carcinoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:8 Pt 2 Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Products; Carcinoma, Hepatocellular; Cyclophosphamide; Doxorubicin; Famotidine; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Injections, Intramuscular; Interleukin-2; Liver Neoplasms; Male; Middle Aged; Picibanil; Quality of Life; Remission Induction	1990